Read the latest news from Accelerate Cambridge ventures, including our startup spotlights and venture updates.
Supersense Technologies, a venture supported by the Accelerate Cambridge programme at Cambridge Judge, is awarded £80,000 to develop a remote monitoring system to allow people living with dementia to stay in their homes as long as possible.
Qureight, a life sciences firm supported by Cambridge Judge Business School, collaborates with AstraZeneca on lung disease research.
How a Masters in Entrepreneurship and support from the Accelerate Cambridge programme at Cambridge Judge Business School culminated in Abiel Ma (MSt 2019) winning the Young Innovator of the Year award for his automatic food waste separation technology.
On International Women’s Day 2023, Becky Cotton (EMBA 2015) has been announced as a winner of an Innovate UK Women in Innovation Award, which recognises trailblazing women entrepreneurs.
Seven ventures or people with ties to the Entrepreneurship Centre at Cambridge Judge Business School are named in the #21toWatch list of science and tech talent in and around Cambridge.
Doing an MBA in the UK can be rewarding, as well as eye opening. It allows you to develop your skills and expand your network across the UK and London and it can give you a whole new perspective on your home country. We talk to some of our recent graduates and ask them why they chose to study for their MBA right on their doorstep, here in the UK.
In this special Insight article, we look at how the Entrepreneurship Centre and Cambridge Centre for Social Innovation at Cambridge Judge Business School are supporting new ventures to improve sustainability in agriculture to meet the demands of a growing global population.
Several firms connected to Cambridge Judge Business School are honoured at the Cambridge Independent Science and Technology Awards.
Qureight, a clinical data analytics company supported by the Accelerate Cambridge programme at Cambridge Judge Business School, just raised £1.5m in seed funding.
Biotech firm bit.bio, which was on the Accelerate Cambridge programme at Cambridge Judge Business School, reprograms stem cells to allow manufacture of human cells.
Contact us with any media enquiries at: